- The biogas plant will process 300,000 tonnes of biomass per year.
- The plant will reduce CO2 emissions by 17,000 tonnes annually.
- Construction starts in March 2017 and will be completed by spring 2018.
- The plant will produce 8 million m3 of natural gas per year.
Project Overview
Novo Nordisk, Novozymes, Bigadan, and Ørsted have signed an agreement to build a biogas plant in Kalundborg, Denmark. The plant will convert residues from Novo Nordisk and Novozymes' factories into bio natural gas, which will be fed into the Danish natural gas grid.
Key Figures
The biogas plant will process approximately 300,000 tonnes of biomass annually, resulting in a CO2 reduction of about 17,000 tonnes per year. The facility will be built on a 50,000 m2 site adjacent to the Asnæs Power Station and will create 15-20 new jobs, including sub-suppliers.
Timeline
Construction of the biogas plant will commence in March 2017, with the plant scheduled for commissioning in the spring of 2018. The plant will have a production capacity of 8 million m3 of natural gas per year, equivalent to the natural gas consumption of approximately 5,000 households.
Operational Details
Bigadan and Ørsted will build and own the biogas plant, while Bigadan will operate it. Novo Nordisk and Novozymes will supply the biomass from their factories in Kalundborg and Novozymes' factory at Fuglebakken in Copenhagen. The biogas produced will replace natural gas, contributing to a greener energy system.
Environmental Impact
The project aims to better utilize residues from enzyme and insulin production, which are based on fermentation processes. After biogas conversion, the remaining biomass will continue to be used as fertilizer, enhancing the sustainability of the production process.
